Research & Development

How Do Parent-Child Views Shape Post-Transplant Outcomes?
Research & Development How Do Parent-Child Views Shape Post-Transplant Outcomes?

I'm thrilled to sit down with Dr. Ivan Kairatov, a renowned expert in pediatric medicine with a focus on liver transplantation and patient-reported outcomes. With years of experience in research and innovation, Dr. Kairatov has been at the forefront of shifting how we understand children's

David Cameron Reveals Prostate Cancer to Urge Early Testing
Research & Development David Cameron Reveals Prostate Cancer to Urge Early Testing

Imagine a silent epidemic affecting thousands of men each year, often undetected until it’s too late, with societal norms discouraging open conversations about personal health challenges, and prostate cancer standing as the most common cancer among men in the UK, with around 55,000 new cases

Can Fu’s Needling Speed Up Wrist Fracture Recovery?
Research & Development Can Fu’s Needling Speed Up Wrist Fracture Recovery?

Wrist fractures, specifically distal radius fractures, rank among the most frequent orthopedic injuries, particularly impacting older adults who are prone to falls or trauma. These injuries often disrupt daily routines with persistent pain and limited mobility, making recovery a frustratingly slow

Is Recursion Pharmaceuticals the Next AI Biotech Giant?
Research & Development Is Recursion Pharmaceuticals the Next AI Biotech Giant?

In the rapidly evolving landscape of biotechnology, few companies have captured the imagination of investors and industry watchers quite like Recursion Pharmaceuticals (NASDARXRX). Headquartered in Salt Lake City, Utah, this clinical-stage “TechBio” firm is at the forefront of a paradigm shift,

World’s First Lung Cancer Vaccine Begins Clinical Trials
Research & Development World’s First Lung Cancer Vaccine Begins Clinical Trials

In a remarkable advancement that could alter the landscape of cancer care, researchers from University College London (UCL) and the University of Oxford have developed LungVax, the world’s first experimental vaccine aimed at preventing lung cancer. This pioneering initiative, now entering clinical

Contineum's Lead MS Drug Fails in Key Clinical Trial
Research & Development Contineum's Lead MS Drug Fails in Key Clinical Trial

What happens when a beacon of hope for millions battling multiple sclerosis (MS) dims in a single clinical trial? In a field where breakthroughs are rare and desperately needed, Contineum Therapeutics, a San Diego-based biotech firm, has hit a significant roadblock with their lead drug, PIPE-307,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later